Alseroxylon

Alseroxylon

Reserpine, the major component of alseroxylon
Clinical data
ATC code	C02AA03 ( WHO )
Identifiers
CAS Number	8001-95-4  Y active moiety:  8063-17-0  Y
DrugBank	DB00386  N
ChemSpider	None
UNII	H192N84N1G active moiety:  H192N84N1G  Y
ChEMBL	ChEMBL1201454  N
Chemical and physical data
Formula	Varies
NY  (what is this?)    (verify)

Alseroxylon (Rautensin, Rauwiloid) is a norepinephrine reuptake inhibitor that has been investigated in the treatment of hypertension ^[1] and angina pectoris and as a sedative in psychosis. ^[2] It was at one time approved for use in the United States, but has since been discontinued. ^[3]

Alseroxylon is a purified fat-soluble extract of the root of Rauvolfia serpentina , containing reserpine and other nonadrenolytic amorphous alkaloids. ^[2]

References

1. Green RS, Davolos D (May 1956). "A long-term study of the effect of crude Rauwolfia serpentina and of its alseroxylon fraction in patients with hypertension". The American Journal of Medicine. 20 (5): 760–73. doi:10.1016/0002-9343(56)90158-9. PMID   13313574.
2. DrugBank DB00386
3. Approved Drug Products with Therapeutic Equivalence Evaluations (33rd ed.). 2013.{{cite book}}: |work= ignored (help)